Biochip implants

In most people s jargon, biochips are not confined to microfluidics. Among many other roles, microfludics adapted from MicroLab technology can be extended for implants to deliver neurotransmitters or inhibitors in Parkinsonism, depression, schizophrenia, and so on, in a targeted and still microfluidic way without need for clumsy and not-so-effective oral administration. Nonetheless, when it comes to the brain, the original electronic and digital capabilities of the products of the computer chip industry are as much in the forefront of the news as their microfluidic potential, to say the least. 

Guiseppi-Elie, A., S. Brahim, G. Slaughter, and K. Ward. 2005. Design of a subcutaneous implantable biochip for monitoring of glucose and lactate. IEEE Sens J 5 (3) 345. 

Abraham, S., S. Brahim, K. Ishihara, and A. Guiseppi-Elie. 2005. Molecularly engineered p(HEMA)-based hydrogels for implant biochip biocompatibility. Biomaterials 26 4767. Bongiovanni, C., T. Ferri, A. Poscia, M. VaralK, R. Santucci, and A. Desideri. 2001. An electrochemical multienzymatic biosensor for determination of cholesterol. Bioelectrochemistry 54 17. 

Abraham, S., S. Brahim, K. Ishihara, and A. Guiseppi-Elie. 2005. Molecularly engineered p(HEMA)-based hydrogels for implant biochip biocompatibility. Biomaterials 26 4767. 

Abdur Rahman AR, Justin G, Guiseppi-Elie A (2009) Towards an implantable biochip for glucose and laedate memitoring using microdisc electrode arrays (MDEAs). Biomed Microelevices 11 75-85... 

---